Navigation Links
EntreMed's ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
Date:10/23/2008

ROCKVILLE, Md., Oct. 23 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the presentation of preclinical data for its Aurora A/angiogenesis kinase inhibitor, ENMD-2076. The data were presented by John Tentler, Ph.D., Division of Medical Oncology, University of Colorado, at the 20th EORTC-NCI-AACR Annual Meeting being held this week in Geneva, Switzerland.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

ENMD-2076 is a novel kinase inhibitor with potent activity against Aurora A and a number of tyrosine kinases linked to cancer and inflammatory diseases. ENMD-2076 demonstrated strong antitumor effects in a xenograft model of human colon cancer. Tumor stasis was seen at dose levels of 100 mg/kg/day, and tumor regression was observed at doses of 200 mg/kg ENMD-2076 per day. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and post-study histological examination of tumors suggest that the antitumor effects of ENMD-2076 are exerted through a combination of antiangiogenic and antiproliferative actions. Further analysis using positron emission tomography (PET) demonstrated a substantial decrease in tumor metabolic activity in animals treated with ENMD-2076.

ENMD-2076 exerts its effects through multiple mechanisms of action, including antiproliferative activity and the inhibition of angiogenesis. ENMD-2076 has demonstrated substantial dose-dependent efficacy as a single agent, including tumor regression, in multiple xenograft models (e.g. breast, colon, leukemia). Aurora kinase
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. EntreMeds Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session
2. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
3. SuperGens MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
4. SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications
5. Grid Dynamics Demonstrates Linear Scalability up to 512 Nodes with GridGain Software on Amazon EC2 Cloud
6. First semiconductor-based PET scanner demonstrates potential to aid in early diagnosis of disease
7. SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
8. ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Metastatic Pancreatic Cancer
9. Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial
10. ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study
11. Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiologys Toughest Questions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., BOCARATON,Fla.,Nov.25/PRNewswire/--Formanybusin...Thenation,slargestandfastestgrowingnetworkofexpert...ised bioidenticalhormones has grownthenumberof p...36physicians -andisinprogresstoaddmorephysician-ow...year. ,, Inthepastyear ,BodyLogicMDhasopened13n...
(Date:11/25/2009)...G,Nov.25/PRNewswire-Asia/--SinovacBiotechLtd.(SVA)...todaythatitexecuted,ajointventure(JV)agreementtoes...inovacDalian).TheJVwillresearch,develop,produce,an...uteitsexpertise,andexperienceindevelopingandcommer...ngitslanduserights,manufacturingfacilitiesand,esta...
(Date:11/25/2009)...GO,Nov.25/PRNewswire-FirstCall/--ArdeaBiosciences,...Pharm.D.,presidentandchiefexecutiveofficer,willpre...e. , ,Presentationdetailsareasfollows:,PiperJaff...ember1,2009,Time:2:00p.m.EasternTime,Location:TheN...//www.corporate-ir.net/ireye/,target=,_blank,titl...
(Date:11/24/2009)...N,Nov.24/PRNewswire-FirstCall/--IES(Nasdaq: IESC )...ionssystemsandservicesforthecommercial,industriala...albusinessgrouphasbeenawardedacontractfromManhatta...bio-safetylab(BSL-4)replacementfacilityattheU.S.Ar...MRIID)atFortDetrickinFrederick,Md. ,, ThenewUSA...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
..., Multiporator , , , , , ...ction Protocol , Protocol No. 4308 915... , , , , , , ...se macrophages, , , ...in bidistilled H 2 O), , , ...
..., Multiporator / Electroporator 2510 , ,... , Transformation Protocol , ..., , , , , , , , ...m , Pseudomonas putida P8, ,...eria, gram negative, , , ...
..., Multiporator / Electroporator 2510 , ,... , Transformation Protocol , ..., , , , , , , , ...m , Pediococcus spp., , ... gram positive, , , ...
Other Biology Technology:RAW 264.7 2Pseudomonas putida 2Pediococcus spp. 2
(Date:11/24/2009)... Rocket science is opening new doors to understan...ffect the hearing of a marine mammal or if they h...al sized X-ray scanners that NASA uses to detect f...ckets is now allowing scientists to peek inside th...etailed three-dimensional replicas of a whale,s he...
(Date:11/24/2009)..., NEW YORK (November 24, 2009) -- ...today a report revealing that the last remaining p...ignificantly due to the rising tide of poaching an...t will help inform Russian officials of what needs...e world,s biggest cat. , The report...
(Date:11/23/2009)... CINCINNATINew research presents strong evidence ...re to both outdoor traffic-related pollution and i...gs than one or the other exposure alone. , Env...Cincinnati (UC) College of Medicine have shown tha...related particles and indoor endotoxin during earl...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2T System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines Adds Discharge Instructions 57786 1T System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines Adds Discharge Instructions 57786 2T System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines Adds Discharge Instructions 57786 3Osseon Receives CE Mark 57784 1Osseon Receives CE Mark 57784 2Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 57782 1Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 57782 2Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 57782 3
...n with epilepsy in developing countries are being ... year, according to an editorial in this week’s BM...d non-governmental organisations in developing cou...able for all. , Of the 35 million people with e...5% receive no treatment at all. As a result, they ...
...ain is yielding vital clues to understanding, diag... findings being presented today at the Seventh Int...dies, featured in a press briefing held at 12:15 p...el pathways and markers for diagnosis and treatmen...Husseini K. Manji, M.D., chief of the Laboratory o...
... are nature’s smallest candles. , These tiny tubes... small that it takes about 100,000 laid side-by-si...e last five years, scientists have discovered that...s, they glow when they are bathed in light. Some g...s. Others glow all over. , Until now, this prope...
Other Biology News:Brain holds clues to bipolar disorder 2Brightening prospects of using fluorescent nanotubes in medical applications 2Brightening prospects of using fluorescent nanotubes in medical applications 3
...Beacon Designer designs oligos for SYBR Green, Taq...on, NASBA and FRET assays. Highly specific primers...y automatically interpreting BLAST search results....e secondary structures identified by connecting to...
Agar (BACTERIOLOGICAL GRADE) from GE Healthcare, formerly Amersham Biosciences
Silencer Validated siRNA 5 nmol from Ambion
SPoT-Light EGFR Probe from Invitrogen
Biology Products: